Outcomes of arteriovenous fistulae compared with heparinbonded and conventional grafts for hemodialysis access

Journal of Vascular Access

Volumn 13, Issue 2, 2012, Pages 163-167

  Charlton Ouw, Kristofer M ^a,b   Nosrati, Naveed ^a   Miller III, Charles C ^c   Coogan, Sheila M ^a,b   Safi, Hazim J ^a,b   Azizzadeh, Ali ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Memorial Hermann Heart and Vascular Institute   (United States)

^c Paul L Foster School of Medicine   (United States)

Author keywords

Arteriovenous fistula; Arteriovenous shunt; Graft occlusion; Heparin; Surgical; Vascular; Vascular patency

Indexed keywords

HEPARIN;

ADOLESCENT; ADULT; AGE; AGED; ARTERIOVENOUS FISTULA; ARTERY STEAL SYNDROME; ARTICLE; BODY MASS; BRACHIOAXILLARY ARTERIOVENOUS GRAFT; BRACHIOCEPHALIC ARTERIOVENOUS GRAFT; COMORBIDITY; COMPARATIVE STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEMATOMA; HEMODIALYSIS; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SEX DIFFERENCE; TERTIARY HEALTH CARE; THROMBOSIS; VASCULAR ACCESS; VASCULAR PATENCY; VEIN GRAFT;

EID: 84867185156     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/JVA.2011.8715     Document Type: Article

References (12)

1. Solesky BC, Huber TS, Berceli SA. Patient-centric analysis of dialysis access outcomes. J Vasc Access 2010;11:31-37.
2. Papanikolaou V, Papagiannis A, Vrochides D, et al. The natural history of vascular access for hemodialysis: a single center study of 2,422 patients. Surgery 2009;145:272-279.
3. Gonzalez E, Kashuk JL, Moore EE, et al. Two-stage brachialbasilic transposition fistula provides superior patency rates for dialysis access in a safety-net population. Surgery 2010;148:687-693.
4. Schild AF, Perez E, Gillaspie E, et al. Arteriovenous fistulae vs. arteriovenous grafts: a retrospective review of 1,700 consecutive vascular access cases. J Vasc Access 2008;9:231-235.
5. Woo K, Doros G, Ng T, et al. Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts. J Vasc Surg. 2009;50:1405-1411.
6. Daenens K, Schepers S, Fourneau I, et al. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1-and 2-year results. J Vasc Surg. 2009;49:1210-1216.
7. Hugl B, Nevelsteen A, Daenens K, et al. PEPE II--a multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below knee bypass surgery: determinants of patency. J Cardiovasc Surg. (Torino) 2009;50:195-203.
8. Losel-Sadee H, Alefelder C. Heparin-bonded expanded polytetrafluoroethylene graft for infragenicular bypass: fiveyear results. J Cardiovasc Surg (Torino) 2009;50:339-343.
9. Davidson I, Hackerman C, Kapadia A, et al. Heparin bonded hemodialysis e-PTFE grafts result in 20% clot free survival benefit. J Vasc Access 2009;10:153-156.
10. Roy-Chaudhury P, Wang Y, Krishnamoorthy M, et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant 2009;24:2786-2791.
11. Akoh, JA. Prosthetic arteriovenous grafts for hemodialysis. J Vasc Access 2009; 10:137-147.
12. Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009;360:2191-2201.